Order Article Reprints

Hotte SJ, Bjarnason GA, Heng DYC, Jewett MAS, Kapoor A, Kollmannsberger C, Maroun J, Mayhew LA, North S, Reaume MN, et al. Progression-Free Survival as a Clinical Trial Endpoint in Advanced Renal Cell Carcinoma. Current Oncology. 2011; 18(s2):11-19. https://doi.org/10.3747/co.v18is2.958

Hotte, S.J., G.A. Bjarnason, D.Y.C. Heng, M.A.S. Jewett, A. Kapoor, C. Kollmannsberger, J. Maroun, L.A. Mayhew, S. North, M.N. Reaume, and et al. 2011. "Progression-Free Survival as a Clinical Trial Endpoint in Advanced Renal Cell Carcinoma" Current Oncology 18, no. s2: 11-19. https://doi.org/10.3747/co.v18is2.958

Hotte, S. J., Bjarnason, G. A., Heng, D. Y. C., Jewett, M. A. S., Kapoor, A., Kollmannsberger, C., Maroun, J., Mayhew, L. A., North, S., Reaume, M. N., Ruether, J. D., Soulieres, D., Venner, P. M., Winquist, E. W., Wood, L., 14, Yong, J. H. E., & Saad, F. (2011). Progression-Free Survival as a Clinical Trial Endpoint in Advanced Renal Cell Carcinoma. Current Oncology, 18(s2), 11-19. https://doi.org/10.3747/co.v18is2.958